KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) EBT (2016 - 2025)

Globus Medical (GMED) has disclosed EBT for 15 consecutive years, with $169.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 586.07% year-over-year to $169.2 million, compared with a TTM value of $605.1 million through Dec 2025, up 401.21%, and an annual FY2025 reading of $605.1 million, up 401.21% over the prior year.
  • EBT was $169.2 million for Q4 2025 at Globus Medical, up from $144.0 million in the prior quarter.
  • Across five years, EBT topped out at $188.2 million in Q2 2025 and bottomed at -$185.1 million in Q4 2022.
  • Average EBT over 5 years is $53.4 million, with a median of $55.7 million recorded in 2021.
  • The sharpest move saw EBT plummeted 1033.75% in 2022, then soared 2148.9% in 2024.
  • Year by year, EBT stood at $19.8 million in 2021, then tumbled by 1033.75% to -$185.1 million in 2022, then soared by 113.5% to $25.0 million in 2023, then fell by 1.31% to $24.7 million in 2024, then surged by 586.07% to $169.2 million in 2025.
  • Business Quant data shows EBT for GMED at $169.2 million in Q4 2025, $144.0 million in Q3 2025, and $188.2 million in Q2 2025.